Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.
Saved in:
| Title: | Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome. |
|---|---|
| Authors: | Hernandez-Jerez AF, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S, Focks A, Millet M, Pelkonen O, Pieper S, Tiktak A, Topping CJ, Widenfalk A, Wilks M, Wolterink G, Angeli K, Recordati C, Van Durseen M, Aiassa E, Lanzoni A, Lostia A, Martino L, Guajardo IPM, Panzarea M, Terron A, Marinovich M |
| Corporate Authors: | EFSA Panel on Plant Protection Products and their Residues (PPR) |
| Source: | EFSA journal. European Food Safety Authority [EFSA J] 2023 Feb 14; Vol. 21 (2), pp. e07744. Date of Electronic Publication: 2023 Feb 14 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley and Sons Ltd Country of Publication: United States NLM ID: 101642076 Publication Model: eCollection Cited Medium: Internet ISSN: 1831-4732 (Electronic) Linking ISSN: 18314732 NLM ISO Abbreviation: EFSA J Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1831-4732 |
|---|---|
| DOI: | 10.2903/j.efsa.2023.7744 |
